202 related articles for article (PubMed ID: 14698783)
1. Dose-dependent biodistribution of [(99m)Tc]DTPA-mannosyl-dextran for breast cancer sentinel lymph node mapping.
Ellner SJ; Hoh CK; Vera DR; Darrah DD; Schulteis G; Wallace AM
Nucl Med Biol; 2003 Nov; 30(8):805-10. PubMed ID: 14698783
[TBL] [Abstract][Full Text] [Related]
2. Detection of gastric and colonic sentinel nodes through endoscopic administration of 99mTc-DTPA-mannosyl-dextran in pigs.
Méndez J; Wallace AM; Hoh CK; Vera DR
J Nucl Med; 2003 Oct; 44(10):1677-81. PubMed ID: 14530486
[TBL] [Abstract][Full Text] [Related]
3. A synthetic macromolecule for sentinel node detection: (99m)Tc-DTPA-mannosyl-dextran.
Vera DR; Wallace AM; Hoh CK; Mattrey RF
J Nucl Med; 2001 Jun; 42(6):951-9. PubMed ID: 11390562
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node accumulation of Lymphoseek and Tc-99m-sulfur colloid using a "2-day" protocol.
Wallace AM; Hoh CK; Limmer KK; Darrah DD; Schulteis G; Vera DR
Nucl Med Biol; 2009 Aug; 36(6):687-92. PubMed ID: 19647175
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node mapping of breast cancer via intradermal administration of Lymphoseek.
Wallace AM; Hoh CK; Darrah DD; Schulteis G; Vera DR
Nucl Med Biol; 2007 Oct; 34(7):849-53. PubMed ID: 17921035
[TBL] [Abstract][Full Text] [Related]
6. Preclinical studies of [(99m)Tc]DTPA-mannosyl-dextran .
Hoh CK; Wallace AM; Vera DR
Nucl Med Biol; 2003 Jul; 30(5):457-64. PubMed ID: 12831982
[TBL] [Abstract][Full Text] [Related]
7. Lymphoseek: a molecular imaging agent for melanoma sentinel lymph node mapping.
Wallace AM; Hoh CK; Ellner SJ; Darrah DD; Schulteis G; Vera DR
Ann Surg Oncol; 2007 Feb; 14(2):913-21. PubMed ID: 17146742
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node mapping of the colon and stomach using lymphoseek in a pig model.
Ellner SJ; Méndez J; Vera DR; Hoh CK; Ashburn WL; Wallace AM
Ann Surg Oncol; 2004 Jul; 11(7):674-81. PubMed ID: 15231522
[TBL] [Abstract][Full Text] [Related]
9. Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy.
Babiera GV; Delpassand ES; Breslin TM; Ross MI; Ames FC; Singletary SE; Kuerer HM; Feig BW; Meric-Bernstam F; Hunt KK
Clin Nucl Med; 2005 Jan; 30(1):11-5. PubMed ID: 15604959
[TBL] [Abstract][Full Text] [Related]
10. Lymphoseek: a molecular radiopharmaceutical for sentinel node detection.
Wallace AM; Hoh CK; Vera DR; Darrah DD; Schulteis G
Ann Surg Oncol; 2003 Jun; 10(5):531-8. PubMed ID: 12794019
[TBL] [Abstract][Full Text] [Related]
11. Does
Rietbergen DD; Pereira Arias-Bouda LM; van der Hage J; Valdés Olmos RA
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(5):275-280. PubMed ID: 34425967
[TBL] [Abstract][Full Text] [Related]
12. Tc-99m tilmanocept versus Tc-99m sulfur colloid in breast cancer sentinel lymph node identification: Results from a randomized, blinded clinical trial.
Unkart JT; Hosseini A; Wallace AM
J Surg Oncol; 2017 Dec; 116(7):819-823. PubMed ID: 28695567
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node identification with radiopharmaceuticals in patients with breast cancer: a comparison of 99mTc-tin colloid and 99mTc-phytate efficiency.
Seok JW; Choi YS; Chong S; Kwon GY; Chung YJ; Kim BG; Park SJ
Breast Cancer Res Treat; 2010 Jul; 122(2):453-7. PubMed ID: 20532977
[TBL] [Abstract][Full Text] [Related]
14. A phase 2 study of (99m)Tc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer.
Leong SP; Kim J; Ross M; Faries M; Scoggins CR; Metz WL; Cope FO; Orahood RC
Ann Surg Oncol; 2011 Apr; 18(4):961-9. PubMed ID: 21331809
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of "one-day" vs "two-day" injection protocols using Tc-99m tilmanocept for sentinel lymph node biopsy in breast cancer.
Unkart JT; Proudfoot J; Wallace AM
Breast J; 2018 Jul; 24(4):526-530. PubMed ID: 29498443
[TBL] [Abstract][Full Text] [Related]
16. Identification of sentinel lymph node in stage I-II breast cancer with lymphoscintigraphy and surgical gamma probe: comparison of Tc-99m MIBI and Tc-99m sulfur colloid.
Arcan P; Ibis E; Aras G; Cam R; Küçük NO
Clin Nucl Med; 2005 May; 30(5):317-21. PubMed ID: 15827399
[TBL] [Abstract][Full Text] [Related]
17. Comparison of [(99m)Tc]tilmanocept and filtered [(99m)Tc]sulfur colloid for identification of SLNs in breast cancer patients.
Baker JL; Pu M; Tokin CA; Hoh CK; Vera DR; Messer K; Wallace AM
Ann Surg Oncol; 2015 Jan; 22(1):40-5. PubMed ID: 25069859
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials.
Wallace AM; Han LK; Povoski SP; Deck K; Schneebaum S; Hall NC; Hoh CK; Limmer KK; Krontiras H; Frazier TG; Cox C; Avisar E; Faries M; King DW; Christman L; Vera DR
Ann Surg Oncol; 2013 Aug; 20(8):2590-9. PubMed ID: 23504141
[TBL] [Abstract][Full Text] [Related]
19. Injection site radioactivity of (99m)Tc-labeled mannosylated dextran for sentinel lymph node mapping.
Yamaguchi A; Hanaoka H; Pirmettis I; Uehara T; Tsushima Y; Papadopoulos M; Arano Y
Mol Pharm; 2015 Feb; 12(2):514-9. PubMed ID: 25423619
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
